Table 2.
HR | 95% CI | P | |
---|---|---|---|
Univariate analysis | |||
Brain metastasis vs extracranial metastases alone | 1.43 | [1.41–1.44] | <.001 |
Multivariable analysis | |||
Brain metastasis vs extracranial metastases alone | 1.56 | [1.54–1.58] | <.001 |
Male vs female sex | 1.13 | [1.12–1.14] | <.001 |
Year of diagnosis (per each year increase) | 0.98 | [0.98–0.98] | <.001 |
Age (per each year increase) | 1.02 | [1.02–1.02] | <.001 |
T-stage | |||
T0 vs T1 | 1.1 | [1.06–1.14] | <.001 |
T2 vs T1 | 1.18 | [1.16–1.20] | <.001 |
T3 vs T1 | 1.12 | [1.10–1.13] | <.001 |
T4 vs T1 | 1.31 | [1.29–1.33] | <.001 |
TX vs T1 | 1.51 | [1.48–1.53] | <.001 |
N-stage | |||
N+ vs N0 | 1.15 | [1.14–1.17] | <.001 |
NX vs N0 | 1.18 | [1.17–1.20] | <.001 |
Race | |||
American Indian/Alaska Native vs white | 1.05 | [1.00–1.11] | .036 |
Asian/Pacific Islander vs white | 0.86 | [0.85–0.87] | <.001 |
Black vs white | 1.08 | [1.06–1.09] | <.001 |
Unknown vs white | 0.51 | [0.46–0.57] | <.001 |
Coexisting lung/bone/ liver metastasis vs no lung/bone/liver metastasis | 1.15 | [1.14–1.16] | <.001 |
HR, hazard ratio; CI, confidence interval.